ducovest

ZEUS:CA:TSX-BMO Shiller Select US Index ETF

ETF | US Equity | Toronto Stock Exchange

Last Closing

CAD 22.67

Change

+0.16 (+0.71)%

Market Cap

CAD 0.02B

Volume

2.65K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Inception Date: 04/10/2017

Primary Benchmark: Shiller Barclays CAPE USSingleStk TR CAD

Primary Index:

Gross Expense Ratio: %

Management Expense Ratio: 0.73 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
AUTL Autolus Therapeutics Ltd 1.40 %
PYT PPLUS Trust Series GSC 2 Pref 1.33 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-04-23 )

Largest Industry Peers for US Equity

Symbol Name Mer Price(Change) Market Cap
ZSP:CA BMO S&P 500 0.09 %

-0.17 (-0.22%)

 CAD 10.81B
XSP:CA iShares Core S&P 500 (CAD Hedg.. 0.11 %

-0.12 (-0.23%)

 CAD 9.71B
VFV:CA Vanguard S&P 500 Index ETF 0.08 %

-0.29 (-0.24%)

 CAD 8.89B
VUN:CA Vanguard US Total Market 0.16 %

-0.22 (-0.24%)

 CAD 7.76B
XUS:CA iShares Core S&P 500 Index ETF 0.11 %

-0.25 (-0.29%)

 CAD 5.73B
HXS:CA Horizons S&P 500 Index ETF 0.11 %

-0.07 (-0.10%)

 CAD 2.95B
QUU:CA Mackenzie US Large Cap Equity .. 0.09 %

-0.85 (-0.43%)

 CAD 2.89B
XUU:CA iShares Core S&P US Total Mark.. 0.07 %

-0.11 (-0.22%)

 CAD 2.68B
XQQ:CA iShares NASDAQ 100 (CAD Hedged.. 0.39 %

-0.84 (-0.63%)

 CAD 2.66B
VSP:CA Vanguard S&P 500 CAD hedged 0.09 %

-0.18 (-0.22%)

 CAD 2.45B

ETFs Containing ZEUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange (Toronto Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.43% 63% D 75% C
Dividend Return 0.41% 26% F 11% F
Total Return 15.84% 61% D- 74% C
Trailing 12 Months  
Capital Gain 7.64% 43% F 81% B-
Dividend Return 1.09% 13% F 7% C-
Total Return 8.74% 30% F 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 0.69% 6% D- 54% F
Dividend Return 1.06% 6% D- 33% F
Total Return 0.37% 9% A- 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 3.52% 98% N/A 85% B
Risk Adjusted Return 30.24% 6% D- 47% F
Market Capitalization 0.02B 34% F 18% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.